Contact
Ross McNaughton

Ross McNaughton

Partner

Read More
Contact
Ross McNaughton

Ross McNaughton

Partner

Read More

15 January 2021

Advising Oxbotica in $47 million Series B investment

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Inside the Office Building
Corporate/M&A & capital markets

Advising on Mission Zero Technologies on its £21.8 million Series A funding

20 March 2024

by Ross McNaughton and Oli Denne

Click here to find out more
Explaining strategy
Corporate/M&A & capital markets

Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million

14 July 2022

by multiple authors

Click here to find out more
White microscope on yellow background
Corporate/M&A & capital markets

Advising New Science Ventures as lead investor on Paragraf's $60 million Series B funding round

4 March 2022

by Ross McNaughton and Adrian Toutoungi

Click here to find out more